Alpha 2.0
Login Register
» Authors » G Calabrese

G Calabrese

Explore the profile of G Calabrese including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 238
Citations 1414
Followers 0
Related Specialties
Genetics
Endocrinology
Nephrology
Top 10 Co-Authors
G Palka
L Stuppia
P Guanciali Franchi
E Morizio
M Gonella
G Vagelli
P Brunetti
R Mingarelli
G Pratesi
G Parruti
Published In
Cancer Genet Cytogenet
Minerva Urol Nefrol
Int J Artif Organs
J Med Genet
J Eur Acad Dermatol Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Experimental characterization of gaseous ion beams produced with the advanced ion source for hadrontherapy (AISHa) at 18 GHz
Castro G, Leonardi O, Chines F, Costanzo G, DAgostino G, Massara A, et al.
Rev Sci Instrum . 2023 Jul; 94(7). PMID: 37417900
The Advanced Ion Source for Hadrontherapy (AISHa) is an electron cyclotron resonance ion source operating at 18 GHz, developed at the Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud, with...
2.
Trocar vs. Seldinger small bore pleural drains: does the technique influence the outcomes? A prospective single-centre study
Congedo M, Chiappetta M, Nachira D, Lococo F, Calabrese G, Tabacco D, et al.
Eur Rev Med Pharmacol Sci . 2023 Feb; 27(2):728-736. PMID: 36734736
Objective: The aim of this study is to compare two positioning techniques of 12-French (Fr) thoracic drains in terms of efficacy, safety, and patient comfort. Patients And Methods: This is...
3.
Is itching in atopic dermatitis still an unmet need? A case series of 556 patients
Tancredi V, Licata G, Calabrese G, Gambardella A, De Rosa A, Alfano R, et al.
J Eur Acad Dermatol Venereol . 2022 Mar; 36(8):e650-e652. PMID: 35353939
No abstract available.
4.
Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature
Licata G, Buononato D, Fiorentino C, Calabrese G, De Rosa A, Argenziano G, et al.
J Eur Acad Dermatol Venereol . 2022 Jan; 36(5):e339-e341. PMID: 35015918
No abstract available.
5.
Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib
Licata G, Gambardella A, Tancredi V, Calabrese G, De Rosa A, Alfano R, et al.
J Eur Acad Dermatol Venereol . 2021 Sep; 36(2):e150-e152. PMID: 34553800
No abstract available.
6.
Aarskog-Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?
Calabrese G, Licata G, Buononato D, Gambardella A, De Rosa A, Argenziano G
Clin Exp Dermatol . 2021 Sep; 47(2):452-453. PMID: 34482546
No abstract available.
7.
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response
Nettis E, Ferrucci S, Pellacani G, Di Leo E, Argenziano G, Foti C, et al.
J Eur Acad Dermatol Venereol . 2021 Jul; 35(12):e896-e898. PMID: 34310749
No abstract available.
8.
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab
Licata G, Gambardella A, Calabrese G, Pagliuca F, Alfano R, Argenziano G
Clin Exp Dermatol . 2021 Jun; 46(8):1594-1595. PMID: 34101231
No abstract available.
9.
Dupilumab and conjunctivitis: a case series of twenty patients
Calabrese G, Gambardella A, Licata G, Di Brizzi E, Alfano R, Argenziano G
J Eur Acad Dermatol Venereol . 2021 Mar; 35(9):e612-e614. PMID: 33657247
No abstract available.
10.
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
Nettis E, Fabbrocini G, Ortoncelli M, Pellacani G, Argenziano G, Di Leo E, et al.
Br J Dermatol . 2020 Sep; 184(3):561-563. PMID: 32998177
No abstract available.